Consensus Panel's Assessment and Recommendations on the Use of 3 Botulinum Toxin Type A Products in Facial Aesthetics

Authors

Z Paul Lorenc
Jeffrey M Kenkel
Steven Fagien
Haideh Hirmand
Mark S Nestor
Anthony P Sclafani, New York Medical CollegeFollow
Jonathan M Sykes
Heidi A Waldorf

Author Type(s)

Faculty

DOI

10.1177/1090820X13480479

Journal Title

Aesthetic Surgery Journal

First Page

35

Last Page

35

Document Type

Article

Publication Date

3-1-2013

Department

Otolaryngology

Abstract

In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.

Recommended Citation

Lorenc, Z., Kenkel, J., Fagien, S., Hirmand, H., Nestor, M., Sclafani, A., Sykes, J., & Waldorf, H. (2013). Consensus Panel's Assessment and Recommendations on the Use of 3 Botulinum Toxin Type A Products in Facial Aesthetics. Aesthetic Surgery Journal, 33 (1 Suppl), 35-35. https://doi.org/10.1177/1090820X13480479